Crystalline (R)-(E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol
- 专利权人:
- Benjamin Alan Diseroad
- 发明人:
- Benjamin Alan Diseroad
- 申请号：
- US13248055
- 公开号：
- US08530665B2
- 申请日:
- 2011.09.29
- 申请国别(地区):
- US
- 年份:
- 2013
- 代理人:
- 摘要：
- The present invention provides crystalline (R)-(E)-2-(4-(2-(5-(1-(3,5 -dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol useful in the treatment of cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- CRYSTALLINE (R)-(E)-2-(4-(2-(5-(1-(3,5-DICHLOROPYRIDIN-4-YL)ETHOXY)-1H-INDAZOL-3-YL)VINYL)-1H-PYRAZOL-1-YL)ETHANOL
- CRYSTALLINE
- Crystalline ((R)-(E) -2- (4- (2- (5- (1- (3,5-dichloropyridin-4-yl) ethoxy) -1H-indazol-3-yl) vinyl)- 1H-pyrazol-1-yl) ethanol and use as FGFR inhibitor
- VINYL INDAZOLYL COMPOUND (E)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1H-indazol-3-yl)vinyl)-1H-pyrazol-1-yl)ethanol
- CRYSTALLINE (R) - (E) -2- (4- (2- (5- (1- (3, 5 -DICHLOROPYRIDIN-4 -YL) ETHOXY) - 1H - INDAZOL - 3 - YL) VINYL) -1 H- PYRAZOL- 1 -YL) ETHANOL AND ITS USE AS FGFR INHIBITOR
